SweetValueLab
Write for us

Eli Lilly and Company — Wall Street Analyst Estimates & Price Targets

LLY
NYSEHealthcareDrug Manufacturers - GeneralCIK 0000059478lilly.comAbout LLY
Last close · Oct 16, 20261,257.03+5.42 (+0.43%)
Market cap$1.2T

8 firms' latest targets, last 90 days: median $1,388.00 ($940.00–$1,440.00), 10% above the last close.

Price and published targets

daily close, 12 months · each dot a target, a firm's latest darker
$800$1,000$1,200$1,400NovJan 2026MarMayJulSep2025-10-31 · Cantor Fitzgerald: $9852025-11-10 · Loop Capital Markets: $9502025-11-19 · Truist: $1,1822025-11-24 · Bernstein: $1,3002025-11-24 · Morgan Stanley: $1,2902025-12-01 · National Bank: $1,2862025-12-02 · BMO Capital: $1,1002025-12-03 · Guggenheim: $1,1632025-12-04 · BMO Capital: $1,2002025-12-10 · HSBC: $1,0702025-12-15 · Goldman Sachs: $1,1452025-12-16 · Daiwa: $1,2302026-01-05 · Leerink Partners: $1,2342026-01-06 · UBS: $1,2502026-01-20 · Guggenheim: $1,1612026-02-05 · Scotiabank: $1,3002026-02-05 · Truist: $1,2812026-02-05 · Goldman Sachs: $1,2602026-02-05 · Wells Fargo: $1,2802026-02-05 · BMO Capital: $1,3002026-02-10 · Loop Capital Markets: $1,2002026-02-19 · Barclays: $1,3502026-02-24 · RBC Capital: $1,2502026-03-05 · Morgan Stanley: $1,3132026-03-06 · Deutsche Bank: $1,2852026-03-13 · Jefferies: $1,3002026-04-10 · Morgan Stanley: $1,3272026-05-01 · Morgan Stanley: $1,3442026-05-01 · Cantor Fitzgerald: $1,2302026-05-05 · Barclays: $1,4002026-05-21 · Wolfe Research: $1,3502026-05-26 · HSBC: $1,2512026-05-26 · Leerink Partners: $1,1192026-06-09 · Jefferies: $1,3502026-06-22 · Berenberg Bank: $1,1352026-06-25 · Leerink Partners: $1,2322026-07-06 · Cantor Fitzgerald: $1,3502026-07-08 · Truist: $1,3702026-07-08 · RBC Capital: $1,5002026-07-08 · Morgan Stanley: $1,3472026-07-09 · UBS: $1,3702026-07-13 · UBS: $1,4252026-07-13 · Guggenheim: $1,2732026-07-14 · Bernstein: $1,3852026-08-06 · Cantor Fitzgerald: $1,4102026-08-06 · Morgan Stanley: $1,4192026-08-06 · Wells Fargo: $1,3302026-08-06 · BMO Capital: $1,4002026-08-07 · UBS: $1,3762026-09-10 · HSBC: $9402026-09-15 · Berenberg Bank: $1,4002026-09-18 · Guggenheim: $1,2842026-10-07 · Morgan Stanley: $1,4302026-10-08 · Cantor Fitzgerald: $1,440
$800$1,000$1,200$1,400NovFebMayAug

Each firm's latest target

last 90 days · 8 firms
DateFirmTargetPreviousChangeVs price thenVs price now
2026-10-08Cantor Fitzgerald$1,440.00$1,410.00▲ 2%+21%+15%
2026-10-07Morgan Stanley$1,430.00$1,419.00▲ 1%+21%+14%
2026-09-18Guggenheim$1,284.00$1,273.00▲ 1%+11%+2%
2026-09-15Berenberg Bank$1,400.00$1,135.00▲ 23%+23%+11%
2026-09-10HSBC$940.00$1,251.00▼ 25%-16%-25%
2026-08-07UBS$1,376.00$1,425.00▼ 3%+17%+9%
2026-08-06Wells Fargo$1,330.00$1,280.00▲ 4%+14%+6%
2026-08-06BMO Capital$1,400.00$1,300.00▲ 8%+20%+11%

Consensus estimates

revenue and EPS by fiscal year · reported years marked
FYRevenueYoYEPSYoYRevenue rangeEPS rangeAnalysts
2023reported$34.1B+20%$5.80-16%est. $33.7B+1%est. $6.2315
2024reported$45.0B+32%$11.71+102%est. $45.1B+0%est. $12.8314
2025reported$65.2B+45%$22.95+96%est. $63.9B+2%est. $23.5918
2026$88.7B+36%$34.97+48%$87.1B–$91.4B$32.88–$37.5621
2027$102.7B+16%$47.35+35%$98.1B–$105.1B$44.10–$50.6720
2028$114.8B+12%$54.14+14%$102.5B–$129.1B$47.01–$63.6626
2029$124.4B+8%$61.50+14%$115.6B–$132.1B$55.90–$66.4824
2030$134.3B+8%$67.55+10%$124.9B–$142.6B$61.39–$73.0114
A reported year shows the company's figures, with the consensus beside it (revenue against it in %). Reported EPS is GAAP diluted; the analysts' EPS usually leaves items such as stock compensation out, so the two are not like for like. Faded: a year the valuation models do not read — they read the first 3, and a later one only while 10 or more analysts cover every year up to it — or one under 5 analysts.

Targets, grades and estimates are quoted from third parties (via Financial Modeling Prep) and are theirs, not ours; each target links to the report it was published in. A firm counts once, at its latest target or grade.